Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ar
|
ENSMUSG00000046532.7 | androgen receptor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_98150871_98151022 | Ar | 2177 | 0.457336 | -0.65 | 1.0e-07 | Click! |
chrX_98149079_98149230 | Ar | 385 | 0.921972 | -0.51 | 5.8e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_122329580_122330425 | 20.67 |
Zfpm1 |
zinc finger protein, multitype 1 |
3696 |
0.15 |
chr4_59292306_59292644 | 19.62 |
Susd1 |
sushi domain containing 1 |
23491 |
0.17 |
chr19_57437648_57437801 | 18.66 |
Gm50271 |
predicted gene, 50271 |
14230 |
0.15 |
chr10_127508848_127510720 | 17.65 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr19_57438064_57438215 | 17.56 |
Gm50271 |
predicted gene, 50271 |
14645 |
0.15 |
chr19_57437860_57438011 | 16.47 |
Gm50271 |
predicted gene, 50271 |
14441 |
0.15 |
chr5_77150984_77151457 | 14.74 |
Chaer1 |
cardiac hypertrophy associated epigenetic regulator 1 |
10968 |
0.14 |
chr9_48723733_48723941 | 14.65 |
Zbtb16 |
zinc finger and BTB domain containing 16 |
112108 |
0.06 |
chr8_94178954_94179363 | 14.62 |
Mt1 |
metallothionein 1 |
53 |
0.95 |
chr3_105808565_105808856 | 14.57 |
Gm5547 |
predicted gene 5547 |
6830 |
0.11 |
chr12_116772061_116772459 | 14.03 |
Gm48119 |
predicted gene, 48119 |
80842 |
0.1 |
chr5_130200680_130200989 | 13.60 |
Rabgef1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
6219 |
0.1 |
chr17_28420185_28420460 | 13.59 |
Fkbp5 |
FK506 binding protein 5 |
1795 |
0.21 |
chr5_122314849_122315338 | 13.53 |
Gm15842 |
predicted gene 15842 |
12671 |
0.1 |
chr15_88850552_88850757 | 12.99 |
Pim3 |
proviral integration site 3 |
11532 |
0.13 |
chr9_103076752_103077059 | 12.94 |
Gm47468 |
predicted gene, 47468 |
8621 |
0.16 |
chr1_33630885_33631502 | 12.81 |
Prim2 |
DNA primase, p58 subunit |
7869 |
0.14 |
chr14_70336335_70336839 | 12.33 |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
2389 |
0.19 |
chr12_85532591_85532965 | 11.48 |
Gm32296 |
predicted gene, 32296 |
3180 |
0.23 |
chrX_123500550_123501093 | 11.37 |
Rps12-ps22 |
ribosomal protein S12, pseudogene 22 |
13606 |
0.18 |
chr8_94354649_94354841 | 11.33 |
Slc12a3 |
solute carrier family 12, member 3 |
301 |
0.82 |
chr2_31006220_31006371 | 10.78 |
Usp20 |
ubiquitin specific peptidase 20 |
3734 |
0.18 |
chr7_126676246_126676573 | 10.74 |
Sult1a1 |
sulfotransferase family 1A, phenol-preferring, member 1 |
23 |
0.93 |
chr17_26592510_26592666 | 10.69 |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
2288 |
0.19 |
chr16_49840220_49840396 | 10.43 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
15058 |
0.25 |
chr4_134760342_134760599 | 10.41 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
7554 |
0.2 |
chr9_110690057_110690208 | 10.38 |
Gm35715 |
predicted gene, 35715 |
15178 |
0.1 |
chr18_50028238_50028565 | 10.29 |
Tnfaip8 |
tumor necrosis factor, alpha-induced protein 8 |
2617 |
0.3 |
chr5_103629198_103629784 | 10.13 |
Slc10a6 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 6 |
88 |
0.95 |
chr6_86832842_86833107 | 10.05 |
2610306M01Rik |
RIKEN cDNA 2610306M01 gene |
16466 |
0.12 |
chr8_126736428_126737199 | 10.03 |
Gm45805 |
predicted gene 45805 |
21521 |
0.23 |
chr1_74971709_74972075 | 9.90 |
Gm37744 |
predicted gene, 37744 |
17640 |
0.11 |
chr12_24645864_24646171 | 9.88 |
Klf11 |
Kruppel-like factor 11 |
5257 |
0.16 |
chr11_115903206_115903415 | 9.77 |
Smim5 |
small integral membrane protein 5 |
3108 |
0.12 |
chr12_108848239_108848390 | 9.76 |
Slc25a47 |
solute carrier family 25, member 47 |
2815 |
0.14 |
chr8_120284949_120285586 | 9.66 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
56811 |
0.1 |
chr18_34515580_34515781 | 9.59 |
n-R5s24 |
nuclear encoded rRNA 5S 24 |
5943 |
0.15 |
chr7_143313646_143313876 | 9.48 |
Gm37364 |
predicted gene, 37364 |
16063 |
0.12 |
chr2_158127868_158128212 | 9.48 |
Gm20412 |
predicted gene 20412 |
10886 |
0.15 |
chr3_103801903_103802124 | 9.35 |
Gm15471 |
predicted gene 15471 |
1116 |
0.26 |
chr4_151902341_151902516 | 9.32 |
Gm37141 |
predicted gene, 37141 |
13986 |
0.16 |
chr10_128779498_128779802 | 9.31 |
Rpsa-ps2 |
ribosomal protein SA, pseudogene 2 |
2400 |
0.13 |
chr17_26883718_26883869 | 9.24 |
Gm17382 |
predicted gene, 17382 |
2382 |
0.14 |
chr5_143625595_143625787 | 9.21 |
Cyth3 |
cytohesin 3 |
3157 |
0.24 |
chr14_75837044_75838069 | 9.18 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr19_32272552_32272859 | 8.98 |
Sgms1 |
sphingomyelin synthase 1 |
4221 |
0.28 |
chr2_167844637_167844967 | 8.98 |
1200007C13Rik |
RIKEN cDNA 1200007C13 gene |
11156 |
0.16 |
chr5_119776223_119776427 | 8.93 |
1700021F13Rik |
RIKEN cDNA 1700021F13 gene |
31342 |
0.14 |
chr7_80542454_80542814 | 8.92 |
Blm |
Bloom syndrome, RecQ like helicase |
7515 |
0.17 |
chr4_119028467_119028820 | 8.87 |
Gm12862 |
predicted gene 12862 |
28158 |
0.08 |
chr11_51916099_51916416 | 8.79 |
Gm39822 |
predicted gene, 39822 |
17291 |
0.14 |
chr3_144760547_144760991 | 8.67 |
Clca3a1 |
chloride channel accessory 3A1 |
72 |
0.95 |
chr2_121289033_121290183 | 8.59 |
Map1a |
microtubule-associated protein 1 A |
8 |
0.96 |
chr14_74646244_74646401 | 8.47 |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A |
5482 |
0.26 |
chr15_76114723_76114988 | 8.47 |
Eppk1 |
epiplakin 1 |
5340 |
0.09 |
chr14_55614607_55615046 | 8.47 |
Rec8 |
REC8 meiotic recombination protein |
3211 |
0.07 |
chr5_123655134_123655301 | 8.42 |
Clip1 |
CAP-GLY domain containing linker protein 1 |
691 |
0.56 |
chr6_120174417_120174862 | 8.41 |
Ninj2 |
ninjurin 2 |
19184 |
0.18 |
chr10_121429894_121430401 | 8.37 |
Gm18730 |
predicted gene, 18730 |
29434 |
0.1 |
chr9_107981626_107982218 | 8.36 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
1032 |
0.19 |
chr3_95674303_95674509 | 8.34 |
Adamtsl4 |
ADAMTS-like 4 |
2745 |
0.15 |
chr11_106806520_106806671 | 8.32 |
Cep95 |
centrosomal protein 95 |
5731 |
0.1 |
chr4_154929190_154929525 | 8.27 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
794 |
0.51 |
chr16_32563013_32563416 | 8.23 |
Gm34680 |
predicted gene, 34680 |
11472 |
0.14 |
chr9_63109018_63109752 | 8.20 |
Gm6082 |
predicted gene 6082 |
7816 |
0.17 |
chr15_97174959_97175545 | 8.16 |
Gm32885 |
predicted gene, 32885 |
8008 |
0.25 |
chr1_74007725_74008174 | 8.14 |
Tns1 |
tensin 1 |
6382 |
0.25 |
chr13_55189694_55190985 | 8.13 |
Nsd1 |
nuclear receptor-binding SET-domain protein 1 |
19443 |
0.12 |
chr3_103801587_103801856 | 8.12 |
Gm15471 |
predicted gene 15471 |
1408 |
0.2 |
chr8_123185685_123185914 | 8.12 |
Dpep1 |
dipeptidase 1 |
443 |
0.62 |
chr17_5970555_5970726 | 8.11 |
Synj2 |
synaptojanin 2 |
4946 |
0.21 |
chr7_17058026_17058724 | 8.02 |
4833404L02Rik |
RIKEN cDNA 4833404L02 gene |
159 |
0.9 |
chr5_72219728_72220029 | 7.99 |
Atp10d |
ATPase, class V, type 10D |
16525 |
0.18 |
chr14_8244059_8244558 | 7.97 |
Acox2 |
acyl-Coenzyme A oxidase 2, branched chain |
2095 |
0.32 |
chr3_104599330_104600023 | 7.92 |
Gm26091 |
predicted gene, 26091 |
1563 |
0.27 |
chr4_43964262_43964601 | 7.92 |
Glipr2 |
GLI pathogenesis-related 2 |
6739 |
0.14 |
chr7_119783476_119783782 | 7.88 |
Acsm3 |
acyl-CoA synthetase medium-chain family member 3 |
2893 |
0.15 |
chr2_152789190_152789395 | 7.87 |
Gm23802 |
predicted gene, 23802 |
16403 |
0.11 |
chr17_28512776_28513118 | 7.85 |
Fkbp5 |
FK506 binding protein 5 |
1590 |
0.18 |
chr8_72268330_72268752 | 7.85 |
Ap1m1 |
adaptor-related protein complex AP-1, mu subunit 1 |
15606 |
0.1 |
chr11_113806939_113807399 | 7.83 |
Sdk2 |
sidekick cell adhesion molecule 2 |
3254 |
0.26 |
chr1_186663482_186663682 | 7.74 |
Tgfb2 |
transforming growth factor, beta 2 |
4573 |
0.19 |
chr14_46830154_46830484 | 7.73 |
Gm10101 |
predicted gene 10101 |
1708 |
0.17 |
chr1_162891926_162892449 | 7.73 |
Fmo2 |
flavin containing monooxygenase 2 |
5672 |
0.19 |
chr7_103870533_103870999 | 7.72 |
Olfr66 |
olfactory receptor 66 |
11475 |
0.06 |
chr11_59960852_59961150 | 7.72 |
Rasd1 |
RAS, dexamethasone-induced 1 |
3943 |
0.14 |
chr6_31113567_31113853 | 7.71 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
2790 |
0.17 |
chr19_24535123_24535505 | 7.64 |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
20475 |
0.18 |
chr7_80763876_80764435 | 7.60 |
Gm44649 |
predicted gene 44649 |
12310 |
0.17 |
chr1_91454299_91454831 | 7.55 |
Per2 |
period circadian clock 2 |
4700 |
0.13 |
chr1_189960465_189960949 | 7.54 |
Smyd2 |
SET and MYND domain containing 2 |
38344 |
0.15 |
chr4_40849590_40849862 | 7.43 |
Mir5123 |
microRNA 5123 |
412 |
0.42 |
chr4_42835630_42835822 | 7.39 |
Fam205a1 |
family with sequence similarity 205, member A1 |
18162 |
0.12 |
chr5_113138666_113139390 | 7.38 |
2900026A02Rik |
RIKEN cDNA 2900026A02 gene |
1042 |
0.35 |
chr6_83137634_83138375 | 7.36 |
Rtkn |
rhotekin |
894 |
0.27 |
chr11_69096542_69097348 | 7.34 |
Per1 |
period circadian clock 1 |
1728 |
0.15 |
chr3_10366480_10366649 | 7.31 |
Chmp4c |
charged multivesicular body protein 4C |
343 |
0.81 |
chr16_20756056_20756215 | 7.31 |
Gm22741 |
predicted gene, 22741 |
10827 |
0.09 |
chr11_119432746_119433095 | 7.29 |
Rnf213 |
ring finger protein 213 |
39820 |
0.1 |
chr19_26613091_26613268 | 7.28 |
Smarca2 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
5909 |
0.2 |
chr15_97004302_97004609 | 7.25 |
Slc38a4 |
solute carrier family 38, member 4 |
15496 |
0.26 |
chr9_65630514_65631119 | 7.24 |
Rbpms2 |
RNA binding protein with multiple splicing 2 |
257 |
0.9 |
chr15_97019465_97019616 | 7.22 |
Slc38a4 |
solute carrier family 38, member 4 |
411 |
0.9 |
chr6_140570167_140570548 | 7.19 |
Plekha5 |
pleckstrin homology domain containing, family A member 5 |
1031 |
0.59 |
chr8_83799666_83799817 | 7.18 |
Gm45778 |
predicted gene 45778 |
50237 |
0.08 |
chr16_32130295_32130491 | 7.18 |
Nrros |
negative regulator of reactive oxygen species |
17488 |
0.1 |
chr8_117198420_117198657 | 7.18 |
Gan |
giant axonal neuropathy |
40401 |
0.14 |
chr10_69219096_69219495 | 7.13 |
Rhobtb1 |
Rho-related BTB domain containing 1 |
90 |
0.97 |
chr11_87368253_87368600 | 7.09 |
Ppm1e |
protein phosphatase 1E (PP2C domain containing) |
9403 |
0.12 |
chr6_67161663_67162061 | 7.09 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
3062 |
0.22 |
chr10_69136344_69136575 | 7.08 |
Gm24172 |
predicted gene, 24172 |
3577 |
0.2 |
chrX_140567765_140568045 | 6.97 |
AL683809.1 |
TSC22 domain family, member 3 (Tsc22d3), pseuodgene |
15694 |
0.17 |
chr9_74930005_74930274 | 6.94 |
Fam214a |
family with sequence similarity 214, member A |
22745 |
0.17 |
chr2_30265842_30266153 | 6.93 |
Phyhd1 |
phytanoyl-CoA dioxygenase domain containing 1 |
206 |
0.87 |
chr18_32543067_32543441 | 6.91 |
Gypc |
glycophorin C |
7836 |
0.2 |
chr4_150785275_150785430 | 6.90 |
Gm13049 |
predicted gene 13049 |
40381 |
0.13 |
chr4_56113152_56114223 | 6.89 |
Gm12520 |
predicted gene 12520 |
49253 |
0.17 |
chr1_85163919_85164982 | 6.86 |
Gm6264 |
predicted gene 6264 |
3587 |
0.13 |
chr16_41242880_41243222 | 6.86 |
Gm47276 |
predicted gene, 47276 |
25274 |
0.22 |
chr5_120471592_120471804 | 6.84 |
Sdsl |
serine dehydratase-like |
1065 |
0.36 |
chr2_4559355_4560175 | 6.80 |
Frmd4a |
FERM domain containing 4A |
9 |
0.98 |
chr5_123223029_123223358 | 6.77 |
Psmd9 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 |
4997 |
0.12 |
chr4_133240465_133240844 | 6.74 |
Map3k6 |
mitogen-activated protein kinase kinase kinase 6 |
164 |
0.92 |
chr13_43231981_43232458 | 6.74 |
Tbc1d7 |
TBC1 domain family, member 7 |
60718 |
0.11 |
chr13_49479531_49479682 | 6.72 |
Tes3-ps |
testis derived transcript 3, pseudogene |
13712 |
0.16 |
chr5_105649498_105649677 | 6.72 |
Lrrc8d |
leucine rich repeat containing 8D |
50382 |
0.13 |
chr8_46482484_46482635 | 6.71 |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
8407 |
0.15 |
chr4_133174572_133174723 | 6.71 |
Wasf2 |
WAS protein family, member 2 |
1354 |
0.35 |
chr1_165765728_165766269 | 6.67 |
Creg1 |
cellular repressor of E1A-stimulated genes 1 |
2252 |
0.15 |
chr13_5604202_5604519 | 6.65 |
Gm35330 |
predicted gene, 35330 |
33232 |
0.23 |
chr1_160233941_160234092 | 6.65 |
Rabgap1l |
RAB GTPase activating protein 1-like |
2149 |
0.22 |
chr11_96931793_96931959 | 6.65 |
Prr15l |
proline rich 15-like |
489 |
0.62 |
chr15_84639502_84639743 | 6.63 |
Prr5 |
proline rich 5 (renal) |
29998 |
0.16 |
chr6_134703019_134703308 | 6.62 |
Borcs5 |
BLOC-1 related complex subunit 5 |
1613 |
0.3 |
chr11_8814546_8814764 | 6.62 |
Gm11990 |
predicted gene 11990 |
7807 |
0.25 |
chr4_145281154_145281467 | 6.59 |
Tnfrsf8 |
tumor necrosis factor receptor superfamily, member 8 |
33837 |
0.14 |
chr6_136857573_136857913 | 6.55 |
Art4 |
ADP-ribosyltransferase 4 |
10 |
0.95 |
chr3_51233510_51233838 | 6.53 |
Gm38357 |
predicted gene, 38357 |
1757 |
0.27 |
chr13_95671451_95671789 | 6.52 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
101 |
0.96 |
chr12_108848066_108848217 | 6.51 |
Slc25a47 |
solute carrier family 25, member 47 |
2988 |
0.13 |
chr19_9989798_9990534 | 6.50 |
Best1 |
bestrophin 1 |
2749 |
0.15 |
chr10_80084809_80085161 | 6.46 |
Sbno2 |
strawberry notch 2 |
9546 |
0.09 |
chr9_63006109_63006399 | 6.46 |
Pias1 |
protein inhibitor of activated STAT 1 |
18330 |
0.17 |
chr1_130763726_130764512 | 6.46 |
Gm28856 |
predicted gene 28856 |
2265 |
0.17 |
chr1_165717889_165718109 | 6.44 |
Gm37073 |
predicted gene, 37073 |
3557 |
0.13 |
chr4_141952103_141952521 | 6.44 |
Fhad1 |
forkhead-associated (FHA) phosphopeptide binding domain 1 |
236 |
0.9 |
chr9_110689854_110690005 | 6.43 |
Gm35715 |
predicted gene, 35715 |
14975 |
0.1 |
chr11_61468901_61469052 | 6.42 |
Rnf112 |
ring finger protein 112 |
14845 |
0.11 |
chr9_44488742_44489142 | 6.38 |
Bcl9l |
B cell CLL/lymphoma 9-like |
1695 |
0.15 |
chr2_27046509_27046662 | 6.38 |
Gm13398 |
predicted gene 13398 |
9300 |
0.1 |
chr13_91874083_91874248 | 6.36 |
Ckmt2 |
creatine kinase, mitochondrial 2 |
2720 |
0.27 |
chr4_154025097_154025557 | 6.35 |
Smim1 |
small integral membrane protein 1 |
289 |
0.82 |
chr8_36677917_36678123 | 6.34 |
Dlc1 |
deleted in liver cancer 1 |
55034 |
0.16 |
chr7_29296957_29297307 | 6.32 |
Dpf1 |
D4, zinc and double PHD fingers family 1 |
6819 |
0.11 |
chr3_38128678_38128843 | 6.29 |
Gm43821 |
predicted gene 43821 |
1431 |
0.43 |
chr4_150745963_150746359 | 6.28 |
Gm16079 |
predicted gene 16079 |
67369 |
0.09 |
chr13_99307813_99308164 | 6.27 |
Ptcd2 |
pentatricopeptide repeat domain 2 |
36717 |
0.15 |
chr11_85492227_85492636 | 6.27 |
Bcas3 |
breast carcinoma amplified sequence 3 |
137 |
0.95 |
chr9_70834466_70834720 | 6.25 |
Gm3436 |
predicted pseudogene 3436 |
17983 |
0.18 |
chr17_29018332_29018483 | 6.24 |
Gm16196 |
predicted gene 16196 |
2510 |
0.13 |
chr1_51288815_51289019 | 6.24 |
Cavin2 |
caveolae associated 2 |
209 |
0.94 |
chr7_114203002_114203160 | 6.21 |
Gm45454 |
predicted gene 45454 |
6007 |
0.22 |
chr11_3146063_3146478 | 6.18 |
Sfi1 |
Sfi1 homolog, spindle assembly associated (yeast) |
86 |
0.95 |
chr6_91659858_91660030 | 6.15 |
Gm45217 |
predicted gene 45217 |
19279 |
0.12 |
chr7_81110071_81110392 | 6.13 |
Slc28a1 |
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
4568 |
0.16 |
chr2_158141871_158142558 | 6.11 |
Tgm2 |
transglutaminase 2, C polypeptide |
2478 |
0.23 |
chr7_46719582_46719911 | 6.08 |
Saa3 |
serum amyloid A 3 |
4046 |
0.1 |
chr8_46750506_46750809 | 6.05 |
Irf2 |
interferon regulatory factor 2 |
10391 |
0.14 |
chr10_54039973_54040637 | 6.05 |
Gm47917 |
predicted gene, 47917 |
23506 |
0.18 |
chr8_124265826_124266211 | 6.03 |
Galnt2 |
polypeptide N-acetylgalactosaminyltransferase 2 |
29085 |
0.14 |
chr11_4036141_4036292 | 6.01 |
Sec14l4 |
SEC14-like lipid binding 4 |
4374 |
0.13 |
chr15_88875576_88876323 | 6.01 |
Pim3 |
proviral integration site 3 |
11029 |
0.13 |
chr17_26592671_26592848 | 6.00 |
Ergic1 |
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
2117 |
0.2 |
chr11_95800592_95800866 | 5.99 |
Phospho1 |
phosphatase, orphan 1 |
23770 |
0.1 |
chr4_41984136_41984287 | 5.98 |
Fam205a4 |
family with sequence similarity 205, member A4 |
18153 |
0.1 |
chr5_150468552_150468707 | 5.97 |
Fry |
FRY microtubule binding protein |
7983 |
0.12 |
chr4_150784890_150785122 | 5.97 |
Gm13049 |
predicted gene 13049 |
40727 |
0.13 |
chr1_135731863_135732606 | 5.96 |
Csrp1 |
cysteine and glycine-rich protein 1 |
3087 |
0.22 |
chr9_35236843_35237011 | 5.96 |
Fam118b |
family with sequence similarity 118, member B |
1482 |
0.26 |
chr12_99207009_99207529 | 5.95 |
Gm19898 |
predicted gene, 19898 |
38402 |
0.13 |
chr2_131223682_131223845 | 5.94 |
Mavs |
mitochondrial antiviral signaling protein |
10300 |
0.1 |
chr10_77440801_77441066 | 5.93 |
Gm35920 |
predicted gene, 35920 |
16984 |
0.15 |
chr9_107312801_107313233 | 5.91 |
Gm17041 |
predicted gene 17041 |
11179 |
0.09 |
chr17_46729109_46729324 | 5.89 |
Gnmt |
glycine N-methyltransferase |
48 |
0.95 |
chr7_109191268_109192295 | 5.89 |
Lmo1 |
LIM domain only 1 |
16574 |
0.17 |
chr4_124769349_124769512 | 5.88 |
Inpp5b |
inositol polyphosphate-5-phosphatase B |
102 |
0.93 |
chr1_155040164_155040623 | 5.87 |
Gm29441 |
predicted gene 29441 |
8654 |
0.18 |
chr11_4031163_4031533 | 5.87 |
Sec14l4 |
SEC14-like lipid binding 4 |
114 |
0.94 |
chr2_167860263_167861115 | 5.86 |
Gm14319 |
predicted gene 14319 |
2104 |
0.29 |
chr14_27349855_27350152 | 5.84 |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
11386 |
0.2 |
chr7_25386312_25386549 | 5.81 |
Lipe |
lipase, hormone sensitive |
1504 |
0.2 |
chr8_46875988_46876273 | 5.80 |
Gm45481 |
predicted gene 45481 |
42218 |
0.13 |
chr10_80962326_80962508 | 5.79 |
Gm3828 |
predicted gene 3828 |
7707 |
0.1 |
chr17_33812964_33813316 | 5.79 |
Kank3 |
KN motif and ankyrin repeat domains 3 |
2611 |
0.11 |
chr9_113968750_113968926 | 5.78 |
Ubp1 |
upstream binding protein 1 |
387 |
0.83 |
chr2_38607587_38607812 | 5.78 |
Gm13586 |
predicted gene 13586 |
15102 |
0.12 |
chr4_135286762_135287375 | 5.78 |
Gm12983 |
predicted gene 12983 |
3607 |
0.15 |
chr17_64721166_64721321 | 5.77 |
Man2a1 |
mannosidase 2, alpha 1 |
7624 |
0.22 |
chr15_81839741_81839959 | 5.77 |
Gm8444 |
predicted gene 8444 |
3863 |
0.11 |
chr3_88923985_88924341 | 5.76 |
Dap3 |
death associated protein 3 |
1379 |
0.25 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 19.4 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
3.3 | 9.9 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
3.1 | 9.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
3.1 | 6.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
2.8 | 8.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.7 | 8.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
2.7 | 8.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
2.6 | 7.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
2.4 | 7.3 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
2.4 | 9.7 | GO:0008228 | opsonization(GO:0008228) |
2.4 | 7.2 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
2.3 | 7.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
2.3 | 7.0 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
2.3 | 9.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.3 | 7.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
2.0 | 6.0 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
2.0 | 2.0 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
1.9 | 1.9 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.9 | 5.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
1.9 | 5.7 | GO:0002432 | granuloma formation(GO:0002432) |
1.8 | 1.8 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.8 | 5.4 | GO:0030576 | Cajal body organization(GO:0030576) |
1.8 | 5.3 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
1.8 | 7.0 | GO:0051031 | tRNA transport(GO:0051031) |
1.7 | 3.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.7 | 5.2 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
1.7 | 6.9 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
1.7 | 6.8 | GO:0003166 | bundle of His development(GO:0003166) |
1.7 | 5.0 | GO:0050904 | diapedesis(GO:0050904) |
1.7 | 6.6 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.6 | 6.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
1.6 | 11.5 | GO:1903961 | positive regulation of anion transmembrane transport(GO:1903961) |
1.6 | 8.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.6 | 4.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.6 | 6.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.6 | 4.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.6 | 7.9 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.6 | 4.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.6 | 1.6 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
1.5 | 6.2 | GO:0009838 | abscission(GO:0009838) |
1.5 | 6.1 | GO:0032264 | IMP salvage(GO:0032264) |
1.5 | 4.5 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.5 | 3.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.5 | 7.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.5 | 10.4 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.5 | 4.5 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.5 | 4.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
1.5 | 4.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.4 | 8.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.4 | 5.6 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.4 | 7.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.4 | 4.2 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
1.4 | 4.2 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.4 | 6.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.4 | 5.5 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
1.4 | 4.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.4 | 6.8 | GO:0070836 | caveola assembly(GO:0070836) |
1.3 | 2.7 | GO:1905049 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
1.3 | 4.0 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.3 | 1.3 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
1.3 | 4.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
1.3 | 5.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.3 | 4.0 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.3 | 3.9 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.3 | 3.9 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
1.3 | 5.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
1.3 | 6.4 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
1.3 | 8.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.2 | 2.5 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.2 | 9.8 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.2 | 4.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.2 | 7.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
1.2 | 3.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
1.2 | 3.6 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
1.2 | 5.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.2 | 2.4 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.2 | 5.9 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.2 | 2.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.2 | 11.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.2 | 2.3 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
1.2 | 3.5 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
1.2 | 2.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.2 | 9.3 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.2 | 1.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.2 | 3.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
1.2 | 2.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.1 | 2.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.1 | 3.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.1 | 17.1 | GO:0051923 | sulfation(GO:0051923) |
1.1 | 4.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
1.1 | 3.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.1 | 5.6 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
1.1 | 1.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
1.1 | 4.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.1 | 4.4 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.1 | 2.2 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
1.1 | 3.3 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.1 | 4.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.1 | 1.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.1 | 3.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.1 | 4.4 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
1.1 | 3.3 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.1 | 7.6 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.1 | 2.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.1 | 2.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.1 | 6.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.1 | 3.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.0 | 1.0 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
1.0 | 2.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.0 | 3.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.0 | 5.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.0 | 10.1 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
1.0 | 2.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
1.0 | 5.0 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
1.0 | 2.0 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
1.0 | 3.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
1.0 | 7.0 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
1.0 | 6.0 | GO:0015871 | choline transport(GO:0015871) |
1.0 | 3.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
1.0 | 2.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
1.0 | 9.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.0 | 2.9 | GO:0051541 | elastin metabolic process(GO:0051541) |
1.0 | 2.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
1.0 | 1.9 | GO:1903798 | regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
1.0 | 6.8 | GO:0060613 | fat pad development(GO:0060613) |
1.0 | 2.9 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.0 | 1.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
1.0 | 8.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.0 | 4.8 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
1.0 | 3.8 | GO:0070295 | renal water absorption(GO:0070295) |
1.0 | 7.7 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.0 | 2.9 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.0 | 4.8 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.0 | 2.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.9 | 3.8 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.9 | 2.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.9 | 0.9 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.9 | 1.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.9 | 2.8 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.9 | 9.4 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.9 | 4.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.9 | 2.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.9 | 0.9 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.9 | 0.9 | GO:0070627 | ferrous iron import(GO:0070627) |
0.9 | 0.9 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.9 | 3.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.9 | 3.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.9 | 2.8 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.9 | 2.7 | GO:0019532 | oxalate transport(GO:0019532) |
0.9 | 3.7 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.9 | 10.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.9 | 1.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.9 | 2.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.9 | 5.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.9 | 2.7 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.9 | 4.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.9 | 5.3 | GO:0060068 | vagina development(GO:0060068) |
0.9 | 3.5 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.9 | 2.6 | GO:0015817 | histidine transport(GO:0015817) |
0.9 | 1.7 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.9 | 1.7 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.9 | 2.6 | GO:0032439 | endosome localization(GO:0032439) |
0.9 | 2.6 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.9 | 7.7 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.8 | 1.7 | GO:0042938 | dipeptide transport(GO:0042938) |
0.8 | 3.4 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.8 | 1.7 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.8 | 2.5 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.8 | 2.5 | GO:0000050 | urea cycle(GO:0000050) |
0.8 | 1.7 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.8 | 3.3 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.8 | 3.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.8 | 11.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.8 | 0.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.8 | 1.6 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.8 | 1.6 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.8 | 2.4 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.8 | 2.4 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.8 | 1.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.8 | 4.0 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.8 | 1.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.8 | 2.4 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.8 | 0.8 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.8 | 8.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.8 | 2.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.8 | 2.4 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.8 | 3.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.8 | 0.8 | GO:0071733 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
0.8 | 3.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.8 | 2.4 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.8 | 1.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.8 | 0.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.8 | 3.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.8 | 2.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.8 | 2.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.8 | 4.6 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.8 | 2.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.8 | 3.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.8 | 3.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.8 | 3.1 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.8 | 16.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.8 | 3.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.8 | 2.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.8 | 3.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.8 | 6.8 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.8 | 3.0 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.8 | 5.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 1.5 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.7 | 5.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.7 | 3.0 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.7 | 2.2 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.7 | 7.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.7 | 12.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.7 | 4.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.7 | 2.2 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.7 | 0.7 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.7 | 6.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.7 | 2.2 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.7 | 2.9 | GO:0018158 | protein oxidation(GO:0018158) |
0.7 | 0.7 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.7 | 4.4 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.7 | 0.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.7 | 3.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.7 | 5.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.7 | 0.7 | GO:0051306 | regulation of mitotic sister chromatid separation(GO:0010965) mitotic sister chromatid separation(GO:0051306) |
0.7 | 10.1 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.7 | 2.2 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.7 | 2.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.7 | 2.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.7 | 1.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.7 | 4.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.7 | 2.8 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.7 | 2.1 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.7 | 7.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.7 | 2.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.7 | 2.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.7 | 6.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.7 | 7.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.7 | 2.8 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.7 | 3.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.7 | 14.6 | GO:0048821 | erythrocyte development(GO:0048821) |
0.7 | 7.6 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.7 | 5.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.7 | 1.4 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.7 | 3.4 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.7 | 2.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.7 | 2.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.7 | 3.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.7 | 2.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.7 | 3.4 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.7 | 0.7 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
0.7 | 4.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 2.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.7 | 2.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.7 | 4.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.7 | 1.3 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.7 | 5.3 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.7 | 2.7 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.7 | 0.7 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.7 | 1.3 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
0.7 | 3.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.7 | 1.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.7 | 2.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.7 | 2.0 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.7 | 3.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.6 | 5.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.6 | 1.3 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
0.6 | 1.9 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.6 | 0.6 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.6 | 3.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 2.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.6 | 3.2 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.6 | 1.3 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.6 | 5.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.6 | 2.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 0.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.6 | 1.3 | GO:1902591 | single-organism membrane budding(GO:1902591) |
0.6 | 0.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.6 | 10.2 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.6 | 1.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.6 | 1.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.6 | 3.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.6 | 1.9 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.6 | 0.6 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.6 | 0.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.6 | 1.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.6 | 1.9 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.6 | 1.9 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.6 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.6 | 0.6 | GO:1901382 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.6 | 10.6 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.6 | 4.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.6 | 1.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.6 | 1.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.6 | 1.8 | GO:0071233 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.6 | 5.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.6 | 1.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.6 | 2.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.6 | 1.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.6 | 0.6 | GO:0051029 | rRNA transport(GO:0051029) |
0.6 | 5.5 | GO:0010225 | response to UV-C(GO:0010225) |
0.6 | 1.8 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.6 | 1.8 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.6 | 3.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.6 | 3.6 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.6 | 3.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.6 | 3.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.6 | 0.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.6 | 1.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.6 | 1.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 1.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.6 | 1.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.6 | 1.2 | GO:0009597 | detection of virus(GO:0009597) |
0.6 | 2.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.6 | 0.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.6 | 1.8 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.6 | 5.9 | GO:1902287 | semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.6 | 3.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.6 | 1.8 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.6 | 5.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.6 | 0.6 | GO:0042044 | fluid transport(GO:0042044) |
0.6 | 0.6 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.6 | 1.2 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.6 | 2.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.6 | 10.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.6 | 2.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.6 | 3.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.6 | 2.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.6 | 3.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.6 | 2.9 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.6 | 8.1 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.6 | 15.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.6 | 1.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.6 | 1.1 | GO:0045472 | response to ether(GO:0045472) |
0.6 | 2.9 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.6 | 2.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.6 | 1.7 | GO:1901163 | trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
0.6 | 0.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.6 | 6.8 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.6 | 1.7 | GO:0061511 | centriole elongation(GO:0061511) |
0.6 | 3.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.6 | 0.6 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.6 | 1.7 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.6 | 1.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.6 | 4.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.6 | 1.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.6 | 1.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.6 | 1.1 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.6 | 1.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.6 | 0.6 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.6 | 0.6 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.6 | 1.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.6 | 2.8 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.6 | 5.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.6 | 1.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.5 | 3.8 | GO:0097286 | iron ion import(GO:0097286) |
0.5 | 1.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.5 | 7.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.5 | 1.1 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.5 | 1.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 1.1 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.5 | 1.1 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.5 | 1.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 2.7 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.5 | 1.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.5 | 3.8 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.5 | 3.2 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.5 | 0.5 | GO:0002159 | desmosome assembly(GO:0002159) |
0.5 | 2.7 | GO:0019695 | choline metabolic process(GO:0019695) |
0.5 | 1.1 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.5 | 1.6 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.5 | 2.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 3.2 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.5 | 4.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.5 | 0.5 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.5 | 3.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.5 | 2.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.5 | 1.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 5.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.5 | 1.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.5 | 1.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.5 | 1.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.5 | 1.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.5 | 2.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 1.0 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
0.5 | 1.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.5 | 1.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.5 | 1.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.5 | 0.5 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 3.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.5 | 0.5 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.5 | 2.0 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 5.6 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.5 | 0.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.5 | 2.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.5 | 5.6 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.5 | 2.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.5 | 1.0 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.5 | 5.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.5 | 2.0 | GO:0061014 | regulation of mRNA catabolic process(GO:0061013) positive regulation of mRNA catabolic process(GO:0061014) |
0.5 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 2.5 | GO:0006907 | pinocytosis(GO:0006907) |
0.5 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 2.0 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.5 | 2.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.5 | 1.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.5 | 0.5 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.5 | 1.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.5 | 2.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.5 | 2.5 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.5 | 3.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.5 | 1.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.5 | 3.4 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.5 | 2.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.5 | 2.5 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 0.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
0.5 | 1.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 2.0 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.5 | 1.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 4.9 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.5 | 3.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.5 | 5.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.5 | 1.9 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.5 | 0.5 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.5 | 1.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.5 | 2.9 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.5 | 0.5 | GO:1901570 | icosanoid biosynthetic process(GO:0046456) fatty acid derivative biosynthetic process(GO:1901570) |
0.5 | 1.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.5 | 1.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.5 | 1.0 | GO:0097320 | membrane tubulation(GO:0097320) |
0.5 | 6.3 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.5 | 1.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.5 | 1.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.5 | 3.9 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.5 | 1.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.5 | 4.8 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.5 | 7.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.5 | 2.9 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.5 | 1.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.5 | 5.7 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.5 | 1.9 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.5 | 4.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.5 | 1.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 2.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 2.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.5 | 4.3 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 0.9 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 1.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.5 | 5.7 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.5 | 0.9 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.5 | 0.9 | GO:0046066 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.5 | 2.8 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.5 | 1.4 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.5 | 3.3 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.5 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.5 | 2.8 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.5 | 2.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.5 | 0.9 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.5 | 0.9 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.5 | 1.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 1.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.5 | 0.5 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.5 | 0.9 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.5 | 25.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.5 | 1.4 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.5 | 2.3 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.5 | 1.4 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.5 | 1.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.5 | 1.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.5 | 9.1 | GO:0014823 | response to activity(GO:0014823) |
0.5 | 1.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.5 | 1.8 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.5 | 0.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 1.8 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.5 | 0.5 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.5 | 0.5 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.5 | 0.5 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.4 | 1.8 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.4 | 1.8 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
0.4 | 0.9 | GO:0090399 | replicative senescence(GO:0090399) |
0.4 | 4.0 | GO:0046697 | decidualization(GO:0046697) |
0.4 | 2.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.4 | 0.9 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.4 | 0.4 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.4 | 0.4 | GO:0061724 | lipophagy(GO:0061724) |
0.4 | 0.9 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 2.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 0.9 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.4 | 2.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.4 | 4.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 2.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.4 | 3.1 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.4 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.4 | 1.8 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 2.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.4 | 1.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.4 | 3.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.4 | 1.7 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.4 | 1.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.4 | 2.2 | GO:0031944 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
0.4 | 0.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.4 | 3.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 0.9 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.4 | 1.7 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.4 | 1.3 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.4 | 0.9 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.4 | 3.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.4 | 1.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.4 | 1.3 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 3.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 0.4 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.4 | 0.4 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.4 | 1.7 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.4 | 1.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.4 | 1.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.4 | 2.9 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.4 | 1.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 0.4 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.4 | 0.8 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.4 | 1.3 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.4 | 1.7 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 4.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.4 | 0.8 | GO:0060596 | mammary placode formation(GO:0060596) |
0.4 | 4.1 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.4 | 1.2 | GO:0000237 | leptotene(GO:0000237) |
0.4 | 1.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 1.6 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.4 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 0.4 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.4 | 4.5 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.4 | 2.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 1.6 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.4 | 1.2 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.4 | 2.0 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 2.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.4 | 1.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.4 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.4 | 0.4 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.4 | 0.4 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.4 | 2.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.4 | 1.6 | GO:0031331 | positive regulation of cellular catabolic process(GO:0031331) |
0.4 | 2.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 0.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.4 | 0.8 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.4 | 2.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 2.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.4 | 0.4 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.4 | 2.4 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.4 | 0.8 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.4 | 0.8 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.4 | 0.8 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.4 | 0.4 | GO:0015677 | copper ion import(GO:0015677) |
0.4 | 0.8 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.4 | 4.0 | GO:0031100 | organ regeneration(GO:0031100) |
0.4 | 1.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 0.8 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 0.4 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
0.4 | 1.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 0.8 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.4 | 2.8 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.4 | 4.0 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.4 | 2.8 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.4 | 1.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.4 | 2.4 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.4 | 1.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
0.4 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 1.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 0.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.4 | 0.4 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.4 | 3.5 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.4 | 1.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.4 | 1.6 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 1.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.4 | 2.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.4 | 0.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.4 | 2.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.4 | 1.5 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.4 | 5.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 2.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 0.4 | GO:0044838 | cell quiescence(GO:0044838) |
0.4 | 0.8 | GO:0009110 | vitamin biosynthetic process(GO:0009110) |
0.4 | 3.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 2.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.4 | 0.8 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.4 | 0.8 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.4 | 3.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 5.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.4 | 2.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.4 | 0.4 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.4 | 1.9 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.4 | 1.1 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.4 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.4 | 1.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 1.5 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 0.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.4 | 0.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 1.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.4 | 0.4 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 0.7 | GO:0031650 | regulation of heat generation(GO:0031650) |
0.4 | 3.7 | GO:0002347 | response to tumor cell(GO:0002347) |
0.4 | 0.4 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.4 | 3.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.4 | 1.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.4 | 0.7 | GO:0019230 | proprioception(GO:0019230) |
0.4 | 1.8 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 1.5 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.4 | 3.7 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.4 | 5.5 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.4 | 13.1 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.4 | 1.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.4 | 0.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.4 | 0.7 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.4 | 0.7 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.4 | 0.7 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.4 | 0.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 0.7 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.4 | 0.7 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.4 | 10.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.4 | 2.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 4.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 0.7 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.4 | 2.9 | GO:0016926 | protein desumoylation(GO:0016926) |
0.4 | 0.7 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.4 | 1.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 1.1 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.4 | 1.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.4 | 1.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 0.7 | GO:2000847 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.3 | 0.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 1.0 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.3 | 1.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.3 | 6.3 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.3 | 0.7 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
0.3 | 1.7 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.3 | 0.3 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.3 | 0.3 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.3 | 1.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 1.0 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.3 | 2.1 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.3 | 0.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.3 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 3.1 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 0.3 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.3 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 1.0 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.3 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 1.7 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 4.1 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.3 | 1.0 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 0.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.3 | 0.3 | GO:0070255 | mucus secretion(GO:0070254) regulation of mucus secretion(GO:0070255) |
0.3 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 9.8 | GO:0015914 | phospholipid transport(GO:0015914) |
0.3 | 3.7 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 1.3 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.3 | 2.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.3 | 1.0 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.3 | 3.0 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 0.3 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.3 | 5.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.3 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 1.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 2.7 | GO:0007097 | nuclear migration(GO:0007097) |
0.3 | 0.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 2.7 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.3 | 2.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 1.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.3 | 4.3 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.3 | 1.7 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.3 | 3.3 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.3 | 1.3 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 1.0 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.7 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 2.6 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.3 | 1.0 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.3 | 0.3 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.3 | 0.3 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.3 | 0.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.3 | 2.3 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.3 | 5.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 2.9 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.3 | 1.0 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.3 | 1.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 1.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 1.0 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.3 | 2.3 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.3 | 0.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 1.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 1.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 5.8 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.3 | 1.0 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.3 | 1.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.3 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.3 | 1.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.9 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 1.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 6.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 1.3 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.3 | 0.9 | GO:0009189 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.3 | 0.6 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 2.5 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.3 | 1.6 | GO:0043297 | apical junction assembly(GO:0043297) |
0.3 | 3.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 1.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 1.9 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.3 | 0.6 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.3 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 0.3 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.3 | 0.6 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 0.9 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 3.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 2.2 | GO:0019985 | translesion synthesis(GO:0019985) |
0.3 | 1.8 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.3 | 2.8 | GO:1901186 | positive regulation of ERBB signaling pathway(GO:1901186) |
0.3 | 0.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.3 | 1.5 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.3 | 1.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 1.5 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
0.3 | 0.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 0.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 10.3 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.3 | 5.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.3 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 3.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 0.6 | GO:0015819 | lysine transport(GO:0015819) |
0.3 | 0.3 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.3 | 0.6 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.3 | 0.9 | GO:0071025 | RNA surveillance(GO:0071025) |
0.3 | 1.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.3 | 0.6 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.3 | 2.4 | GO:1904851 | regulation of establishment of protein localization to telomere(GO:0070203) positive regulation of establishment of protein localization to telomere(GO:1904851) |
0.3 | 0.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.3 | 1.2 | GO:0046415 | urate metabolic process(GO:0046415) |
0.3 | 0.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.3 | 7.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.3 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.3 | 0.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.3 | 1.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 0.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 0.3 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 0.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.3 | 0.9 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.3 | 1.7 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.3 | 6.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 0.9 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 0.6 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 2.3 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.3 | 1.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 0.9 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.3 | 0.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 1.1 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.3 | 0.6 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.3 | 0.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 3.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.3 | 2.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 5.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.3 | 0.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 0.6 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.3 | 0.3 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.3 | 1.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 1.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.3 | 2.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.3 | 1.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.3 | 1.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.3 | 1.7 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
0.3 | 0.3 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
0.3 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.3 | 0.6 | GO:0071692 | sequestering of BMP in extracellular matrix(GO:0035582) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.3 | 0.6 | GO:0035927 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.3 | 2.5 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.3 | 1.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 1.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.3 | 2.5 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.3 | 1.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 1.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.3 | 2.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 9.6 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 0.3 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.3 | 3.0 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.6 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.3 | 1.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 1.9 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.3 | 0.5 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) negative regulation of cardiac muscle cell differentiation(GO:2000726) |
0.3 | 0.3 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.3 | 3.8 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.3 | 0.3 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 1.9 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.3 | 9.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.3 | 3.5 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 8.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 0.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 0.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.3 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 0.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.3 | 0.8 | GO:1902268 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 1.9 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 1.3 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 0.5 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.3 | 1.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.3 | 1.6 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.3 | 0.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.3 | 0.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 2.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 0.8 | GO:0046952 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.3 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 0.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.3 | 1.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.3 | 1.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 1.8 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 2.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.3 | 1.5 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.3 | 7.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 5.9 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.3 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 1.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 3.6 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 1.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 0.8 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 0.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 1.5 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 0.3 | GO:0002576 | platelet degranulation(GO:0002576) |
0.3 | 0.5 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.3 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.3 | 0.5 | GO:0042255 | ribosome assembly(GO:0042255) |
0.3 | 1.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 1.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.3 | 1.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.3 | 0.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 1.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.3 | 0.8 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.3 | 1.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 0.8 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.3 | 0.8 | GO:1902622 | regulation of neutrophil migration(GO:1902622) |
0.2 | 0.7 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.2 | 1.7 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.5 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.2 | 4.2 | GO:0001562 | response to protozoan(GO:0001562) |
0.2 | 0.2 | GO:0034367 | macromolecular complex remodeling(GO:0034367) protein-lipid complex remodeling(GO:0034368) plasma lipoprotein particle remodeling(GO:0034369) |
0.2 | 0.7 | GO:0090199 | regulation of release of cytochrome c from mitochondria(GO:0090199) |
0.2 | 0.5 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 3.4 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 1.2 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 0.2 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 1.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 0.5 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.2 | 9.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.2 | 0.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 1.0 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.2 | 0.2 | GO:0002001 | renin secretion into blood stream(GO:0002001) |
0.2 | 1.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 3.3 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.2 | 1.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 1.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.2 | 0.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 5.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 2.1 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.2 | 0.5 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 1.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 3.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 1.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 3.8 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.2 | 1.4 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.7 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 0.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 1.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 2.3 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 1.4 | GO:0046051 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.2 | 0.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.5 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.2 | 0.7 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.2 | 1.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.2 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 0.7 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 0.5 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 2.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 0.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 2.0 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.2 | 1.6 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.2 | 0.5 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 1.6 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.2 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 2.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.2 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.2 | 5.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 2.0 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.2 | 0.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.4 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.4 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.2 | 0.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.2 | 0.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 0.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 4.2 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.2 | 2.2 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.2 | 0.4 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.2 | 0.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 0.4 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 0.4 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.2 | 0.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 1.7 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.9 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 1.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.2 | GO:0046112 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) nucleobase biosynthetic process(GO:0046112) |
0.2 | 0.6 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.2 | 0.2 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.2 | 6.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.2 | 2.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.2 | 0.2 | GO:2001225 | regulation of chloride transport(GO:2001225) |
0.2 | 0.2 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 0.6 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.2 | 0.2 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.2 | 0.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 0.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 2.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.2 | 1.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.2 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.2 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
0.2 | 0.4 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.2 | 0.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.2 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.2 | 0.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.4 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.2 | 1.0 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.2 | 1.4 | GO:0001556 | oocyte maturation(GO:0001556) |
0.2 | 0.2 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.2 | 0.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 1.0 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.6 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 0.2 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.2 | 0.2 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.2 | 1.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 1.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 0.8 | GO:0046503 | glycerolipid catabolic process(GO:0046503) |
0.2 | 0.4 | GO:2000516 | positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
0.2 | 3.0 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.2 | 1.0 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.6 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 2.8 | GO:0043489 | RNA stabilization(GO:0043489) |
0.2 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.2 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 0.2 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.2 | 0.2 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.2 | 0.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.2 | 0.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 0.4 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 2.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 1.4 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.2 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.2 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.2 | 2.3 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.2 | 1.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.2 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.2 | 1.7 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.2 | 0.8 | GO:0051492 | regulation of stress fiber assembly(GO:0051492) |
0.2 | 1.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.2 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) |
0.2 | 0.4 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.2 | 0.2 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.2 | 1.3 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.2 | 9.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.2 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.4 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.2 | 0.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 0.6 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.2 | 0.4 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.2 | 1.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.6 | GO:0071599 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.2 | 0.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.2 | 0.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.7 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.2 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.7 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.2 | 0.4 | GO:0002254 | kinin cascade(GO:0002254) |
0.2 | 1.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 1.1 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.2 | 0.7 | GO:0033059 | cellular pigmentation(GO:0033059) |
0.2 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 3.0 | GO:0006073 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.2 | 0.5 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.2 | 0.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.2 | 0.2 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.2 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.4 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.2 | 0.4 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 1.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 0.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.2 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.2 | 2.3 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.2 | 0.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 2.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.3 | GO:0015682 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.2 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.3 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.2 | 1.0 | GO:0090224 | regulation of spindle organization(GO:0090224) |
0.2 | 0.7 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.2 | 0.2 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
0.2 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.2 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.2 | 0.7 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 0.8 | GO:0071711 | basement membrane organization(GO:0071711) |
0.2 | 0.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.2 | 0.3 | GO:0031579 | membrane raft organization(GO:0031579) |
0.2 | 0.2 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 0.7 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 1.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 0.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 1.5 | GO:0002385 | mucosal immune response(GO:0002385) |
0.2 | 0.3 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.7 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.2 | 1.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 0.7 | GO:0061526 | acetylcholine secretion(GO:0061526) |
0.2 | 0.7 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.2 | GO:0032095 | regulation of response to food(GO:0032095) |
0.2 | 0.8 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.2 | 2.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.8 | GO:0014002 | astrocyte development(GO:0014002) |
0.2 | 1.3 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.2 | 1.0 | GO:0030261 | chromosome condensation(GO:0030261) |
0.2 | 0.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.3 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.2 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.2 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 0.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 1.0 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.2 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.2 | 4.4 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 0.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.2 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.2 | 1.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.6 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.2 | 0.5 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 1.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.2 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.2 | 1.4 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.2 | 7.8 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.2 | 0.8 | GO:0048753 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.2 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.3 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.2 | 0.5 | GO:0019086 | late viral transcription(GO:0019086) |
0.2 | 0.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.2 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 4.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.6 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.2 | 0.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.2 | 0.2 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 | 0.6 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.4 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 1.0 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 1.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.3 | GO:0039531 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039531) |
0.1 | 0.1 | GO:0046036 | CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.1 | 1.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 4.2 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.1 | 0.9 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.6 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 6.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.1 | 6.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.1 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.3 | GO:0055119 | relaxation of cardiac muscle(GO:0055119) |
0.1 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.6 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 1.1 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 1.8 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.7 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.1 | 0.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.1 | GO:0060416 | response to growth hormone(GO:0060416) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.8 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.4 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
0.1 | 1.4 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 1.0 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.3 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.3 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 1.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.1 | 0.8 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.9 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.3 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.1 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.3 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.1 | 0.3 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.7 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.1 | 1.5 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 3.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.1 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 1.2 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 1.6 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.1 | 0.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 3.2 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.4 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.6 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.5 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.4 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.5 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.9 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.1 | 0.1 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.4 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 1.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.1 | 0.2 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.4 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.9 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.2 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.1 | 0.6 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.1 | 0.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 2.5 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.2 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.1 | 1.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.1 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.1 | 0.3 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 1.4 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.1 | 0.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.5 | GO:0010324 | membrane invagination(GO:0010324) |
0.1 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.1 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 1.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.1 | 1.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.3 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.1 | 1.1 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.7 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.1 | 0.3 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.4 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.1 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.8 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.1 | 2.6 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 0.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.1 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.6 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.1 | 0.2 | GO:0070305 | response to cGMP(GO:0070305) |
0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.1 | 0.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.2 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.1 | GO:0007418 | ventral midline development(GO:0007418) floor plate morphogenesis(GO:0033505) |
0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.2 | GO:0007135 | meiosis II(GO:0007135) |
0.1 | 0.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 3.1 | GO:0015758 | glucose transport(GO:0015758) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.3 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.1 | 0.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.4 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 1.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.8 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.5 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.1 | 0.3 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.1 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.1 | GO:1904037 | positive regulation of epithelial cell apoptotic process(GO:1904037) |
0.1 | 0.3 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.1 | GO:0042747 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.1 | 0.3 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.1 | GO:1900118 | negative regulation of execution phase of apoptosis(GO:1900118) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.0 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.6 | GO:0030104 | water homeostasis(GO:0030104) |
0.1 | 0.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.3 | GO:0090155 | regulation of sphingolipid biosynthetic process(GO:0090153) negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) regulation of membrane lipid metabolic process(GO:1905038) |
0.1 | 0.1 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.1 | GO:0009218 | pyrimidine ribonucleotide metabolic process(GO:0009218) |
0.1 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.1 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.1 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.1 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.2 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.1 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.5 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.1 | 0.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.1 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.1 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.2 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.6 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 1.9 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 0.3 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.2 | GO:0070542 | response to fatty acid(GO:0070542) |
0.1 | 0.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.2 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.7 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.1 | 0.9 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.2 | GO:0051125 | regulation of actin nucleation(GO:0051125) |
0.1 | 0.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 6.1 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.1 | 0.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.2 | GO:0019068 | virion assembly(GO:0019068) |
0.1 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.2 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.1 | 0.2 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
0.1 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 2.7 | GO:0035264 | multicellular organism growth(GO:0035264) |
0.1 | 1.3 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 1.0 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 0.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 0.3 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.5 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.1 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.3 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.1 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.2 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.1 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.1 | 1.5 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.1 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.1 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.1 | 0.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.1 | 1.2 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 1.7 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 3.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.5 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 3.8 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.3 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:0072378 | blood coagulation, intrinsic pathway(GO:0007597) blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.1 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.1 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.1 | 0.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.1 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 4.8 | GO:0071222 | cellular response to lipopolysaccharide(GO:0071222) |
0.1 | 0.3 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 6.1 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.8 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.1 | 0.2 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.5 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.4 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.1 | 0.2 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 1.0 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 0.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.1 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 1.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.5 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.4 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.1 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.1 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.6 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.6 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.1 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 0.1 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.7 | GO:0006949 | syncytium formation(GO:0006949) |
0.1 | 0.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.1 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.2 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 0.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.4 | GO:0007098 | centrosome cycle(GO:0007098) |
0.1 | 0.7 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.2 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.1 | GO:1902931 | negative regulation of alcohol biosynthetic process(GO:1902931) |
0.1 | 0.1 | GO:0051324 | M phase(GO:0000279) meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.1 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.3 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.3 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.1 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.1 | 0.8 | GO:0070229 | negative regulation of lymphocyte apoptotic process(GO:0070229) |
0.1 | 0.2 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.1 | 0.3 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.1 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 0.1 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 0.0 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.0 | 0.3 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.1 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 3.6 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.0 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.0 | 0.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:0072180 | mesonephric duct development(GO:0072177) nephric duct formation(GO:0072179) mesonephric duct morphogenesis(GO:0072180) |
0.0 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.4 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.1 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 1.6 | GO:0050912 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.0 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.0 | 0.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.0 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0051985 | negative regulation of chromosome segregation(GO:0051985) |
0.0 | 0.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.5 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.1 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.0 | 0.2 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.0 | 0.0 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.1 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.8 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.0 | 0.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.0 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.0 | 0.0 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.0 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.0 | 0.1 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.0 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 3.4 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.2 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.2 | GO:0010596 | negative regulation of endothelial cell migration(GO:0010596) |
0.0 | 0.1 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0045123 | cellular extravasation(GO:0045123) |
0.0 | 0.0 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.0 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.0 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.0 | GO:0021610 | facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
0.0 | 1.4 | GO:0007596 | blood coagulation(GO:0007596) coagulation(GO:0050817) |
0.0 | 4.4 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.0 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 0.1 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.1 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.1 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.0 | 0.3 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.0 | 0.0 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.0 | 0.0 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.0 | 0.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.0 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.0 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.0 | 0.0 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.0 | 0.1 | GO:0000819 | sister chromatid segregation(GO:0000819) |
0.0 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.1 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.0 | 0.0 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.0 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.0 | GO:0007622 | rhythmic behavior(GO:0007622) |
0.0 | 0.0 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.0 | 0.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.0 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.0 | 0.3 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 4.5 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.1 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.1 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.0 | 0.0 | GO:0045346 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) |
0.0 | 0.3 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.1 | GO:0000045 | autophagosome assembly(GO:0000045) |
0.0 | 0.7 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.0 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.0 | 0.0 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.0 | 0.9 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.0 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.0 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.0 | GO:0009624 | response to nematode(GO:0009624) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.0 | 0.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.1 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.0 | 0.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.3 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.0 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 8.6 | GO:0097443 | sorting endosome(GO:0097443) |
2.2 | 8.9 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.1 | 10.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.9 | 9.7 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.8 | 1.8 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
1.5 | 7.6 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.5 | 9.0 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.4 | 4.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.4 | 6.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.3 | 4.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.3 | 5.4 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.3 | 11.9 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.3 | 4.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.3 | 3.9 | GO:0097413 | Lewy body(GO:0097413) |
1.2 | 4.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.2 | 3.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.1 | 7.9 | GO:0090543 | Flemming body(GO:0090543) |
1.1 | 5.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.0 | 8.4 | GO:0030056 | hemidesmosome(GO:0030056) |
1.0 | 8.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
1.0 | 4.1 | GO:0042583 | chromaffin granule(GO:0042583) |
1.0 | 3.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.0 | 4.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.0 | 3.9 | GO:0071203 | WASH complex(GO:0071203) |
1.0 | 4.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.9 | 9.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 2.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.9 | 2.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.9 | 3.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.9 | 9.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.9 | 4.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.9 | 4.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.8 | 1.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.8 | 2.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.8 | 2.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.8 | 3.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.8 | 3.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.8 | 8.1 | GO:0032982 | myosin filament(GO:0032982) |
0.8 | 2.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.8 | 3.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.8 | 6.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.8 | 6.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.8 | 3.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.8 | 3.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.7 | 2.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.7 | 6.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 3.6 | GO:0070938 | contractile ring(GO:0070938) |
0.7 | 2.1 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.7 | 3.5 | GO:0045180 | basal cortex(GO:0045180) |
0.7 | 2.8 | GO:0071817 | MMXD complex(GO:0071817) |
0.7 | 5.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.7 | 1.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.7 | 2.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.7 | 2.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 2.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.7 | 2.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.7 | 2.0 | GO:0070552 | BRISC complex(GO:0070552) |
0.7 | 2.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.7 | 2.7 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.7 | 8.0 | GO:0031528 | microvillus membrane(GO:0031528) |
0.7 | 6.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.7 | 2.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.7 | 2.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.7 | 5.2 | GO:0045179 | apical cortex(GO:0045179) |
0.6 | 8.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.6 | 2.6 | GO:0042825 | TAP complex(GO:0042825) |
0.6 | 1.9 | GO:1990423 | RZZ complex(GO:1990423) |
0.6 | 14.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.6 | 2.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.6 | 2.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.6 | 1.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.6 | 12.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.6 | 4.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 35.1 | GO:0005811 | lipid particle(GO:0005811) |
0.6 | 0.6 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.6 | 2.4 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.6 | 1.8 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.6 | 1.8 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.6 | 11.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.6 | 2.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.6 | 1.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.6 | 2.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.6 | 2.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.6 | 3.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 0.6 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.6 | 6.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 3.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.6 | 2.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.6 | 2.2 | GO:0000938 | GARP complex(GO:0000938) |
0.6 | 0.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 2.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.5 | 4.4 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 6.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.5 | 2.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 1.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.5 | 2.7 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 4.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.5 | 16.9 | GO:0031672 | A band(GO:0031672) |
0.5 | 1.6 | GO:0008091 | spectrin(GO:0008091) |
0.5 | 6.3 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 1.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.5 | 2.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.5 | 1.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.5 | 0.5 | GO:0043218 | compact myelin(GO:0043218) Schmidt-Lanterman incisure(GO:0043220) |
0.5 | 1.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.5 | 1.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 1.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.5 | 4.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 1.0 | GO:0032994 | protein-lipid complex(GO:0032994) plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.5 | 4.4 | GO:0090544 | BAF-type complex(GO:0090544) |
0.5 | 2.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.5 | 2.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.5 | 1.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.5 | 12.1 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.5 | 1.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.5 | 1.9 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.5 | 6.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.5 | 1.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.5 | 2.3 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 1.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.5 | 32.5 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.5 | 2.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 1.8 | GO:0030689 | Noc complex(GO:0030689) |
0.5 | 26.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.5 | 30.3 | GO:0016605 | PML body(GO:0016605) |
0.5 | 4.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.5 | 1.8 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 1.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 2.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.4 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.4 | 2.7 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 4.9 | GO:0042581 | specific granule(GO:0042581) |
0.4 | 3.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.4 | 7.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 12.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.4 | 3.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.4 | 1.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 1.7 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 2.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 3.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.4 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 2.6 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 1.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.4 | 3.0 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 7.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 2.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.4 | 0.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.4 | 4.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 1.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 5.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.4 | 2.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 4.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 1.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 9.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 1.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.4 | 6.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.4 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 1.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.4 | 0.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 2.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.4 | 0.8 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.4 | 2.3 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.4 | 0.8 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 1.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.4 | 1.5 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 2.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 3.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.4 | 0.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 0.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.4 | 1.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.4 | 104.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.4 | 1.9 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 3.0 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 0.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.4 | 0.7 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
0.4 | 4.7 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 0.7 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.4 | 0.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.4 | 1.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 1.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 3.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 1.0 | GO:1990923 | PET complex(GO:1990923) |
0.3 | 1.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.3 | 2.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 32.2 | GO:0005903 | brush border(GO:0005903) |
0.3 | 1.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 1.0 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 3.4 | GO:0002102 | podosome(GO:0002102) |
0.3 | 0.7 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 2.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 4.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 1.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 0.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 1.0 | GO:0000243 | commitment complex(GO:0000243) |
0.3 | 0.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.3 | 5.3 | GO:0030894 | replisome(GO:0030894) |
0.3 | 1.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 7.6 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 0.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 0.3 | GO:0097452 | GAIT complex(GO:0097452) |
0.3 | 0.7 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 3.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 13.4 | GO:0005795 | Golgi stack(GO:0005795) |
0.3 | 2.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.3 | 17.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 1.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.3 | 0.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 1.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 3.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.3 | 2.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.6 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.3 | 0.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 1.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 24.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 3.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.3 | 4.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 6.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.3 | 0.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 0.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.3 | 0.3 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 1.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.3 | 1.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.3 | 2.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 11.4 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.3 | 2.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.3 | 0.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.3 | 2.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.3 | 0.9 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 1.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 0.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.3 | 2.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 1.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 1.7 | GO:0042599 | lamellar body(GO:0042599) |
0.3 | 1.7 | GO:0000796 | condensin complex(GO:0000796) |
0.3 | 0.9 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 0.9 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 2.2 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.3 | 0.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 4.1 | GO:0005844 | polysome(GO:0005844) |
0.3 | 3.3 | GO:0008305 | integrin complex(GO:0008305) |
0.3 | 1.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 3.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 1.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 8.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.3 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.3 | 0.5 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 0.5 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 23.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.3 | 0.8 | GO:0044194 | cytolytic granule(GO:0044194) |
0.3 | 5.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 1.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 11.1 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 2.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 1.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.3 | 5.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 0.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 2.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.3 | 2.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 1.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 4.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 3.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.7 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 3.0 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 2.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 4.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 1.8 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.2 | 0.5 | GO:0043256 | laminin-3 complex(GO:0005608) laminin complex(GO:0043256) |
0.2 | 0.7 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 2.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.2 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 1.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 0.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 3.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 2.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 1.5 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 4.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 4.4 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 2.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 5.1 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.2 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 0.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 9.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.2 | 2.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.2 | 0.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 61.6 | GO:0005813 | centrosome(GO:0005813) |
0.2 | 1.4 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.2 | 1.4 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 5.2 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.2 | 9.5 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.2 | 0.4 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 6.7 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 5.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 8.6 | GO:0005901 | caveola(GO:0005901) |
0.2 | 1.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 1.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 0.4 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.2 | 1.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.8 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.2 | 0.5 | GO:0090661 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 0.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 17.6 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.2 | 1.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 22.3 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.2 | 1.2 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 1.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.5 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 1.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 1.9 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 1.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 0.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.9 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.2 | 2.4 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 2.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 3.0 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 7.5 | GO:0031514 | motile cilium(GO:0031514) |
0.2 | 4.6 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 1.4 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.2 | 1.7 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 24.3 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 1.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 3.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.7 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 7.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 3.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.6 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 124.0 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 10.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.7 | GO:0044452 | nucleolar part(GO:0044452) |
0.1 | 0.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 2.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 0.4 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 0.1 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 8.7 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.3 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 3.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.1 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 9.6 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 1.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 15.8 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 2.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 2.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 3.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 5.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 1.0 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.1 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 3.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 1.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 1.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.8 | GO:0000801 | central element(GO:0000801) |
0.1 | 3.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.8 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.2 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 2.5 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 12.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.2 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.1 | 2.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.4 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 1.9 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 14.5 | GO:0098552 | side of membrane(GO:0098552) |
0.1 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.6 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.1 | GO:0016528 | sarcoplasm(GO:0016528) |
0.1 | 4.8 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 2.0 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.1 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 2.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 2.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 5.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 1.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 3.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 98.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 1.7 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.2 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 2.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 1.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 1.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 13.9 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 43.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.1 | 0.1 | GO:0000805 | X chromosome(GO:0000805) |
0.0 | 1.2 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 2.3 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 1.5 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.3 | GO:0043230 | extracellular organelle(GO:0043230) |
0.0 | 22.6 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.0 | 2.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 22.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 3.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.0 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.0 | 4.3 | GO:0044429 | mitochondrial part(GO:0044429) |
0.0 | 14.8 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 5.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0036128 | CatSper complex(GO:0036128) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 11.7 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
2.9 | 11.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
2.7 | 8.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
2.7 | 10.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
2.7 | 8.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
2.6 | 10.4 | GO:0009374 | biotin binding(GO:0009374) |
2.6 | 7.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
2.3 | 6.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
2.1 | 8.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
2.0 | 6.0 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.9 | 5.7 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.9 | 9.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.8 | 14.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
1.8 | 5.4 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.8 | 7.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.8 | 7.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.8 | 10.6 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.7 | 6.8 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
1.6 | 4.9 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
1.5 | 4.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
1.4 | 4.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.4 | 5.7 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.4 | 4.2 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.4 | 11.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.4 | 4.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.3 | 6.7 | GO:0016936 | galactoside binding(GO:0016936) |
1.3 | 7.9 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.3 | 2.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.3 | 6.5 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.3 | 3.8 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
1.3 | 5.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.2 | 7.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.2 | 7.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
1.2 | 2.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.2 | 3.5 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
1.2 | 8.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.2 | 3.5 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
1.1 | 3.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.1 | 3.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.1 | 4.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.1 | 4.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.1 | 3.3 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.1 | 3.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.1 | 5.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.1 | 3.2 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.1 | 11.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.1 | 7.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.1 | 8.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.0 | 9.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.0 | 13.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.0 | 18.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
1.0 | 4.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.0 | 7.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.0 | 4.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.0 | 12.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.0 | 8.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.0 | 4.0 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.0 | 8.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.0 | 5.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.0 | 3.8 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.9 | 12.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.9 | 5.7 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.9 | 3.8 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.9 | 5.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.9 | 1.9 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.9 | 1.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.9 | 3.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.9 | 2.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.9 | 5.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.9 | 2.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.9 | 4.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.9 | 4.5 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.9 | 1.8 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.9 | 2.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.9 | 2.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.9 | 3.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.9 | 3.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.9 | 2.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.9 | 0.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.9 | 4.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.9 | 6.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 2.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.9 | 1.7 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.8 | 2.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.8 | 7.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.8 | 2.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 3.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.8 | 4.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.8 | 5.8 | GO:0018649 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.8 | 2.4 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.8 | 2.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.8 | 2.4 | GO:0055100 | adiponectin binding(GO:0055100) |
0.8 | 4.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.8 | 16.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.8 | 0.8 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.8 | 3.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.8 | 9.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.8 | 1.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.8 | 1.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.8 | 3.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.8 | 8.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.8 | 6.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.8 | 7.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.8 | 5.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.8 | 4.6 | GO:0043426 | MRF binding(GO:0043426) |
0.8 | 5.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.8 | 3.0 | GO:0038100 | nodal binding(GO:0038100) |
0.8 | 2.3 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.8 | 4.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.8 | 9.1 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.8 | 3.8 | GO:0070728 | leucine binding(GO:0070728) |
0.7 | 6.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.7 | 3.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 2.2 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.7 | 2.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 4.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.7 | 2.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.7 | 3.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.7 | 2.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.7 | 3.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.7 | 0.7 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.7 | 2.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.7 | 0.7 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.7 | 1.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.7 | 2.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.7 | 2.8 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.7 | 8.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.7 | 7.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 7.0 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.7 | 2.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.7 | 2.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.7 | 2.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.7 | 8.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.7 | 3.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.7 | 4.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.7 | 2.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.7 | 1.4 | GO:0050692 | DBD domain binding(GO:0050692) |
0.7 | 2.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.7 | 8.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.7 | 6.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.7 | 1.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.7 | 8.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.7 | 5.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.7 | 9.1 | GO:0005521 | lamin binding(GO:0005521) |
0.7 | 2.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.6 | 5.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.6 | 2.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.6 | 0.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.6 | 4.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.6 | 1.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.6 | 2.5 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.6 | 3.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.6 | 3.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.6 | 2.5 | GO:0031005 | filamin binding(GO:0031005) |
0.6 | 1.2 | GO:0048038 | quinone binding(GO:0048038) |
0.6 | 5.5 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.6 | 1.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.6 | 1.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.6 | 4.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.6 | 1.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.6 | 3.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.6 | 0.6 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.6 | 26.4 | GO:0005507 | copper ion binding(GO:0005507) |
0.6 | 1.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.6 | 1.8 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.6 | 4.7 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 3.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.6 | 5.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.6 | 2.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.6 | 1.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.6 | 0.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 1.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.6 | 2.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 4.5 | GO:0008430 | selenium binding(GO:0008430) |
0.6 | 2.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.6 | 16.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.6 | 1.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.6 | 2.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.6 | 2.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 1.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.6 | 2.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.5 | 2.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.5 | 1.6 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.5 | 7.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.5 | 1.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 2.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.5 | 1.6 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.5 | 2.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 6.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.5 | 1.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 2.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 1.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.5 | 4.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.5 | 4.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.5 | 10.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 2.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.5 | 9.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 1.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.5 | 12.1 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.5 | 1.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.5 | 1.1 | GO:0016419 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.5 | 2.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.5 | 1.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.5 | 1.6 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 3.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.5 | 0.5 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.5 | 3.6 | GO:0015266 | protein channel activity(GO:0015266) |
0.5 | 7.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.5 | 1.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.5 | 3.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.5 | 2.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.5 | 1.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.5 | 1.5 | GO:0043199 | sulfate binding(GO:0043199) |
0.5 | 4.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.5 | 1.5 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 1.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.5 | 2.5 | GO:0031013 | troponin I binding(GO:0031013) |
0.5 | 2.0 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.5 | 3.0 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.5 | 1.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.5 | 5.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 4.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 1.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.5 | 5.3 | GO:0043176 | amine binding(GO:0043176) |
0.5 | 2.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 1.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.5 | 1.4 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.5 | 0.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 6.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.5 | 2.9 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.5 | 1.4 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.5 | 1.9 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.5 | 2.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 0.9 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 1.9 | GO:0005534 | galactose binding(GO:0005534) |
0.5 | 1.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.5 | 1.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.5 | 2.8 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 3.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 3.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.5 | 9.5 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.5 | 5.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 1.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 1.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 2.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.8 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.4 | 1.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.4 | 4.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.4 | 1.3 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.4 | 27.2 | GO:0008565 | protein transporter activity(GO:0008565) |
0.4 | 4.0 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 9.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.4 | 0.9 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.4 | 6.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.4 | 2.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 1.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.4 | 4.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.4 | 12.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.4 | 4.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 1.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 2.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 6.8 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 3.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 1.3 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 0.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.4 | 1.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.4 | 2.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 2.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.4 | 1.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 2.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.4 | 2.9 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 7.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.4 | 1.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 3.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.4 | 0.8 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 0.4 | GO:1901474 | L-histidine transmembrane transporter activity(GO:0005290) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.4 | 0.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 2.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 2.4 | GO:0018449 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.4 | 12.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.4 | 1.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.4 | 2.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.4 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 3.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.4 | 0.4 | GO:0051373 | FATZ binding(GO:0051373) |
0.4 | 4.0 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.4 | 0.4 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.4 | 2.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 8.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.4 | 4.8 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.4 | 2.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.4 | 4.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 7.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 4.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 5.9 | GO:0090484 | drug transmembrane transporter activity(GO:0015238) drug transporter activity(GO:0090484) |
0.4 | 13.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.4 | 2.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 3.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.4 | 2.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 10.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 11.6 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.4 | 2.6 | GO:0050700 | CARD domain binding(GO:0050700) |
0.4 | 1.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.4 | 1.9 | GO:0035671 | enone reductase activity(GO:0035671) |
0.4 | 1.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 1.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 0.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.4 | 1.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.4 | 5.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.1 | GO:0036403 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.4 | 1.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.4 | 1.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 2.9 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.4 | 1.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.4 | 2.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.4 | 1.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.4 | 2.2 | GO:0005536 | glucose binding(GO:0005536) |
0.4 | 1.4 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 1.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.4 | 3.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 6.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 2.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 5.7 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 1.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.4 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.4 | 1.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 0.7 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.4 | 1.1 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) bisphosphoglycerate phosphatase activity(GO:0034416) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.4 | 3.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.3 | 0.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 8.7 | GO:0043914 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.3 | 2.1 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.3 | 5.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 6.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.3 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.3 | 0.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 1.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 2.0 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 1.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 2.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.3 | 0.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 1.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.3 | 3.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 0.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.3 | 1.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.3 | 1.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 1.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 2.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.3 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 3.9 | GO:0071814 | lipoprotein particle binding(GO:0071813) protein-lipid complex binding(GO:0071814) |
0.3 | 1.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.3 | 1.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 3.5 | GO:0008061 | chitin binding(GO:0008061) |
0.3 | 0.6 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 0.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 0.6 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity(GO:0004532) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.3 | 3.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 1.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.3 | 1.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.3 | 0.3 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.3 | 0.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 0.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 1.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 28.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.3 | 0.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.3 | 3.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 2.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.3 | 2.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.3 | 3.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 11.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 1.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 17.4 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.3 | 4.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 5.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 0.6 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.3 | 5.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.3 | 5.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 0.9 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 4.1 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 0.9 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 0.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.3 | 3.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 3.4 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 2.0 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.3 | 2.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 4.2 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.3 | 3.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 0.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 1.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 1.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.3 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.3 | 1.9 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 0.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.3 | 2.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 5.4 | GO:0030515 | snoRNA binding(GO:0030515) |
0.3 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.3 | 0.8 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.3 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 1.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.3 | 8.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.3 | 1.3 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.3 | 4.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 0.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 2.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 10.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 0.8 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.3 | 1.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.3 | 0.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 1.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 3.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 0.8 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.3 | 1.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 9.8 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 1.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.3 | 0.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 0.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.3 | 2.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 1.8 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 1.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.3 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 3.0 | GO:0001848 | complement binding(GO:0001848) |
0.3 | 1.0 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 0.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.2 | 1.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 7.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 0.7 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.2 | 0.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 10.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.2 | 1.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 2.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 1.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 10.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.2 | 1.7 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.2 | 1.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 3.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.2 | 0.5 | GO:0019862 | IgA binding(GO:0019862) |
0.2 | 1.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 1.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 0.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.7 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.2 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.5 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 1.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.2 | 1.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
0.2 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 15.0 | GO:0002020 | protease binding(GO:0002020) |
0.2 | 0.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 1.2 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.2 | 1.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 2.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 1.4 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 1.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 1.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 0.9 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 1.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 0.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.2 | 0.7 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 2.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 1.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 2.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 4.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.2 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 0.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.2 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.2 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 2.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.4 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 2.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 1.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 2.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 2.1 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.2 | 1.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 1.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 1.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 0.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 1.2 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 8.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 1.6 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.4 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 18.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 1.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 0.2 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.4 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.2 | 4.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.2 | 1.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.2 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 1.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.2 | 0.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 1.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 4.9 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.2 | 24.7 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 1.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 1.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.6 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 0.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 4.6 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 34.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 1.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.9 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.2 | 0.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.2 | 3.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 0.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.2 | GO:0019003 | GDP binding(GO:0019003) |
0.2 | 1.6 | GO:0034843 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 1.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 4.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 0.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.2 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.9 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 0.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.7 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 1.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 1.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 1.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 0.5 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 14.6 | GO:0019902 | phosphatase binding(GO:0019902) |
0.2 | 0.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 1.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.2 | 0.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.2 | 1.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 2.7 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 2.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 4.0 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.2 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 1.2 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.7 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 7.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.2 | 11.1 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 0.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.2 | 4.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 2.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.2 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 30.9 | GO:0060589 | GTPase regulator activity(GO:0030695) nucleoside-triphosphatase regulator activity(GO:0060589) |
0.2 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 0.5 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 0.3 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.2 | 3.3 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.2 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 5.2 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 0.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 0.6 | GO:0005499 | vitamin D binding(GO:0005499) |
0.2 | 3.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 8.4 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 1.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 5.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 21.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.2 | 2.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.8 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.2 | 1.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 0.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 2.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 1.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.7 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.6 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 0.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 1.0 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 1.2 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 3.2 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.2 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 1.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.6 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 1.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 2.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.7 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 1.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 3.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.7 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 1.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.4 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.1 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 2.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 25.8 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.3 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 1.7 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 0.4 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 1.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.1 | GO:0051427 | hormone receptor binding(GO:0051427) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.2 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 1.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.2 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.3 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.7 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.3 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.1 | 0.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 1.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.1 | 2.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.6 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 2.3 | GO:0019207 | kinase regulator activity(GO:0019207) |
0.1 | 3.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.1 | 0.1 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.5 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 2.6 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 2.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 2.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.8 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.3 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 1.0 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.8 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.3 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 2.0 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 0.3 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.1 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 5.2 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 1.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 0.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.4 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 0.7 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 2.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 9.7 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 2.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 7.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 1.3 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 2.8 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 1.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 3.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.1 | 1.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 9.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.1 | 0.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 0.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 1.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 1.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.4 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 2.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 37.8 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.1 | 9.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 2.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.2 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.1 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.8 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 5.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.1 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.8 | GO:0016875 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 5.2 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.1 | GO:0018600 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 0.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.0 | GO:0048030 | disaccharide binding(GO:0048030) |
0.0 | 1.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.7 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 1.2 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.0 | 0.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
0.0 | 0.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 12.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 1.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.0 | 9.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.9 | 0.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.9 | 25.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.9 | 8.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.8 | 5.0 | PID FGF PATHWAY | FGF signaling pathway |
0.8 | 2.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.8 | 21.9 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.8 | 20.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.8 | 45.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.7 | 18.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.7 | 8.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.7 | 7.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.7 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.7 | 1.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.6 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.6 | 1.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.6 | 21.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.6 | 5.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 7.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.6 | 4.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.6 | 4.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.6 | 1.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 18.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.6 | 10.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.6 | 4.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.6 | 7.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.6 | 8.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.6 | 14.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.6 | 26.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.5 | 19.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.5 | 10.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 5.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 7.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.5 | 6.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.5 | 2.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 20.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 9.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 1.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.5 | 0.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 9.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.5 | 5.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 4.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 3.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.4 | 2.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.4 | 7.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 4.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.4 | 1.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 2.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 1.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.4 | 2.4 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 15.0 | PID E2F PATHWAY | E2F transcription factor network |
0.4 | 8.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.4 | 3.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 8.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.4 | 4.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 3.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 16.4 | PID P73PATHWAY | p73 transcription factor network |
0.4 | 0.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.4 | 4.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 14.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 1.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 5.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.3 | 2.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 4.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 3.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 2.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 0.3 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.3 | 10.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 6.4 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 0.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 8.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 2.0 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 5.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 4.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 7.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 1.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 5.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 2.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 7.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 3.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 46.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 3.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 2.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 1.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.2 | 0.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 5.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.2 | 3.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 0.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 6.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 2.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 1.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 1.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 3.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 3.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 4.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.2 | 0.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 0.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 2.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 3.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 4.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 3.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 3.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 0.7 | PID ATM PATHWAY | ATM pathway |
0.1 | 1.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 3.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.9 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 1.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.2 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 1.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 4.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.0 | PID REELIN PATHWAY | Reelin signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 16.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.1 | 10.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
1.1 | 12.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.1 | 8.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.1 | 10.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.0 | 12.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.0 | 17.7 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.0 | 8.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.9 | 11.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.9 | 7.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.9 | 0.9 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.9 | 8.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.8 | 19.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.8 | 10.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.8 | 4.0 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.8 | 8.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.8 | 14.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.8 | 7.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.8 | 0.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.8 | 10.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.7 | 7.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.7 | 10.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.7 | 8.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.7 | 8.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.7 | 7.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.7 | 8.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.7 | 0.7 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.7 | 7.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.7 | 6.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.6 | 14.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.6 | 6.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 8.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.6 | 12.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.6 | 12.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.6 | 6.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.6 | 16.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 10.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.6 | 2.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.6 | 12.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.6 | 6.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.5 | 5.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.5 | 17.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.5 | 16.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.5 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.5 | 1.6 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.5 | 14.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 4.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.5 | 4.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.5 | 2.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.5 | 2.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.5 | 0.5 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.5 | 0.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 4.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 2.4 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 1.4 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.5 | 8.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 5.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.5 | 20.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.5 | 3.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.5 | 7.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.5 | 1.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.5 | 1.8 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.5 | 6.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 6.0 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.4 | 3.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 4.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 1.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.4 | 4.3 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.4 | 4.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 5.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 9.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.4 | 2.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.4 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 2.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.4 | 4.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.4 | 30.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.4 | 15.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.4 | 2.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.4 | 3.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.4 | 2.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 3.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.4 | 0.4 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 4.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.4 | 1.5 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.4 | 0.8 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.4 | 24.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 8.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 4.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 33.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 1.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.4 | 9.5 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 4.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 5.2 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 14.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 4.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.3 | 3.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 2.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.3 | 2.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.3 | 0.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.3 | 4.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 1.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 5.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 2.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 0.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 5.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.3 | 4.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 5.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 0.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 7.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.3 | 3.5 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 1.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.3 | 3.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 1.5 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.3 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 15.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.3 | 0.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 4.0 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.3 | 4.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.3 | 0.3 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.3 | 1.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 1.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 7.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 5.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.3 | 0.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 5.5 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.3 | 2.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.3 | 0.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 1.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.3 | 1.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 3.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 11.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 2.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 4.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 6.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 5.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 2.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 2.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 6.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 0.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 2.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 1.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 4.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 28.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.2 | 0.7 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.2 | 2.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.2 | 1.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 6.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 3.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 2.8 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 11.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 4.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 0.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.2 | 0.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 4.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 0.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 3.3 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.2 | 1.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.2 | 1.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 3.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 0.6 | REACTOME S PHASE | Genes involved in S Phase |
0.2 | 5.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.2 | 9.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 1.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 1.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 4.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 1.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 1.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 0.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 1.6 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.2 | 2.9 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 4.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 1.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 0.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.2 | 1.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 1.7 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 3.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 0.7 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.2 | 5.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 6.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 2.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 0.5 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 1.9 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.2 | 1.1 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 2.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 2.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 3.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.6 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |
0.1 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.3 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 1.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 3.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 0.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 6.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 12.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 3.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.3 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 1.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 5.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 4.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 0.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 1.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 2.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.3 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.1 | 0.9 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 3.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.5 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 5.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.7 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.8 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 0.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 1.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 1.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.3 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |